Page last updated: 2024-10-21

3-aminobenzamide and Brain Damage, Chronic

3-aminobenzamide has been researched along with Brain Damage, Chronic in 1 studies

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research Excerpts

ExcerptRelevanceReference
" The authors examined whether genetic deletion of PARP (PARP null mice) or its pharmacologic inhibition by 3-aminobenzamide (3-AB) attenuates tissue injury after transient cerebral ischemia."3.69Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. ( Endres, M; Moskowitz, MA; Namura, S; Waeber, C; Wang, ZQ, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endres, M1
Wang, ZQ1
Namura, S1
Waeber, C1
Moskowitz, MA1

Other Studies

1 other study available for 3-aminobenzamide and Brain Damage, Chronic

ArticleYear
Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1997, Volume: 17, Issue:11

    Topics: Animals; Benzamides; Brain; Brain Damage, Chronic; Brain Ischemia; Cerebral Infarction; DNA Damage;

1997